MedPath

Mind-body Medicine for Patients With Malignant Hematological Diseases

Not Applicable
Recruiting
Conditions
Hematologic Neoplasms
Registration Number
NCT03735992
Lead Sponsor
Universität Duisburg-Essen
Brief Summary

This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
94
Inclusion Criteria
  • Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation
  • Physical and mental ability to attent 8 of 11 group units
Exclusion Criteria
  • Chemotherapy, radiation, or rehabilitation programm during the study period
  • Pregnancy
  • Participation in other studies with behavioral interventions during the study period

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
General Fatigueweek 12

Multidimensional Fatigue Inventory (MFI) - General Fatigue Subscale

Secondary Outcome Measures
NameTimeMethod
Reduced Motivationweek 24

Multidimensional Fatigue Inventory (MFI) - Reduced Motivation Subscale

Mental Fatigueweek 24

Multidimensional Fatigue Inventory (MFI) - Mental Fatigue Subscale

Depressionweek 24

Hospital Anxiety and Depression Scale - Depression subscale (HADS-D)

Anxietyweek 24

Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)

Sleepweek 24

Pittsburgh Sleep Quality Index (PSQI)

General Fatigueweek 24

Multidimensional Fatigue Inventory (MFI) - General Fatigue Subscale

Physical Fatigueweek 24

Multidimensional Fatigue Inventory (MFI) - Physical Fatigue Subscale

Reduced Activityweek 24

Multidimensional Fatigue Inventory (MFI) - Reduced Activity Subscale

Qaulity of lifeweek 24

Functional Assessment of Cancer Therapy - General (FACT-G)

Adverse Eventsweek 24

Number of patients with adverse events

Stressweek 24

Perceived Stress Scale (PSS)

Physical activityweek 24

Motion sensor (activPAL3, Pal Technologies, Glasgow, Schottland)

Fatigabilityweek 24

30-Second Chair Stand Test

Trial Locations

Locations (1)

Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin

🇩🇪

Stuttgart, Germany

Robert-Bosch-Krankenhaus, Abteilung für Hämatologie, Onkologie und Palliativmedizin
🇩🇪Stuttgart, Germany
Walter E. Aulitzky, Prof. MD
Contact
walter.aulitzky@rbk.de
Maria M. Winkler
Contact
marcela.winkler@rbk.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.